Title |
ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies
|
---|---|
Published in |
Acta Neuropathologica Communications, May 2013
|
DOI | 10.1186/2051-5960-1-11 |
Pubmed ID | |
Authors |
Karen E Murphy, Louise Cottle, Amanda M Gysbers, Antony A Cooper, Glenda M Halliday |
Abstract |
ATP13A2 (PARK9) loss of function mutations are a genetic cause of an early-onset form of Parkinson's disease (PD), with in vitro studies showing that ATP13A2 deficits lead to lysosomal and mitochondrial dysfunction and α-synuclein accumulation, while elevated ATP13A2 expression reduces α-synuclein toxicity. The three human brain tissue studies assessing changes in ATP13A2 expression in PD produced divergent results; mRNA is increased while protein levels were observed to be either increased or decreased. This apparent conflict in protein levels might have arisen from examining Lewy body disease cases with coexisting Alzheimer-type pathologies.To assess whether ATP13A2 levels in Lewy body disease are modified by Alzheimer-type β-amyloid deposition, we evaluated cases of pure PD and pure dementia with Lewy bodies (DLB) for changes in ATP13A2, α-synuclein and β-amyloid protein levels in cortical regions with and without Lewy bodies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 67% |
Colombia | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 71 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 18% |
Student > Ph. D. Student | 13 | 18% |
Student > Master | 10 | 14% |
Student > Bachelor | 6 | 8% |
Student > Doctoral Student | 4 | 6% |
Other | 10 | 14% |
Unknown | 15 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 13 | 18% |
Neuroscience | 12 | 17% |
Biochemistry, Genetics and Molecular Biology | 12 | 17% |
Medicine and Dentistry | 7 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 6 | 8% |
Unknown | 19 | 27% |